Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of the microbiome in drug resistance in gastrointestinal cancers
Ingrid Garajová, Rita Balsano, Heling Wang, et al.
Expert Review of Anticancer Therapy (2020) Vol. 21, Iss. 2, pp. 165-176
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy
Yibo He, Qianran Hong, Shiliang Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
A journey into the regulatory secrets of the de novo purine nucleotide biosynthesis
Nour Ayoub, Antoine Gedeon, Hélène Munier‐Lehmann
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Romy Aarnoutse, Janine Ziemons, Lars E. Hillege, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Common themes in antimicrobial and anticancer drug resistance
Mariana Carmen Chifiriuc, Roxana Filip, Marian Constantin, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 26
Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches
Priyankar Dey, Saumya Ray Chaudhuri
Biology (2022) Vol. 11, Iss. 5, pp. 757-757
Open Access | Times Cited: 25
Gut microbiota, an emergent target to shape the efficiency of cancer therapy
Soumaya Kouidhi, O. Zidi, Zeineb Belkhiria, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 240-265
Open Access | Times Cited: 14
The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine
Sara Mousa, Muhammad Sarfraz, Walaa K. Mousa
Metabolites (2023) Vol. 13, Iss. 5, pp. 674-674
Open Access | Times Cited: 14
New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer
Zhipeng Li, Xiyang Ke, Zuo Dan, et al.
Nutrients (2022) Vol. 15, Iss. 1, pp. 48-48
Open Access | Times Cited: 22
Metabolic interactions of host-gut microbiota: New possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future—A review
Jianing Yu, Lu Li, Xufeng Tao, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104480-104480
Open Access | Times Cited: 4
The Intersection of the Upper Gastrointestinal Microbiome and Oesophageal Cancer: A Review of Pathways and Therapeutic Insights
Jenny Bui, Kevin R. Ward, Rishindra M. Reddy
European Medical Journal (2025)
Open Access
Predictive biomarkers for immunotherapy in gastric cancer
Sijia Li, Huayuan Liang, Guoxin Li
Journal of Cancer Metastasis and Treatment (2025)
Open Access
The human microbiome: redefining cancer pathogenesis and therapy
Yogita K. Adlakha, Ravindresh Chhabra
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Gastrointestinal cancer resistance to treatment: the role of microbiota
Leila Sadeghi, Fatemeh Vahidian, Majid Eterafi, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Decoding the Tumor-Associated Microbiota: From Origins to Nanomedicine Applications in Cancer Therapy
Ruiqi Wang, Weizheng Li, Hongqian Cao, et al.
Biology (2025) Vol. 14, Iss. 3, pp. 243-243
Open Access
Comparison of Treatment Efficacy and Survival Outcomes Between Asian and Western Patients With Unresectable Gastric or Gastro-Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis
Zhening Zhang, Zining Liu, Zeyang Chen
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Pancreatic Cancer Resistance to Treatment: The Role of Microbiota
Enrico Celestino Nista, Angelo Del Gaudio, Livio Enrico Del Vecchio, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 157-157
Open Access | Times Cited: 9
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 959-1020
Closed Access | Times Cited: 8
Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective
Concetta Panebianco, Davide Ciardiello, A. Villani, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 997-1007
Closed Access | Times Cited: 19
Potential Antitumor Effect of Functional Yogurts Formulated with Prebiotics from Cereals and a Consortium of Probiotic Bacteria
Alexandru Cîrîc, Nicoleta Radu, Marilena Gabriela Zaharie, et al.
Foods (2023) Vol. 12, Iss. 6, pp. 1250-1250
Open Access | Times Cited: 7
Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Ehsan Irajizad, Ranran Wu, Jody V. Vykoukal, et al.
Frontiers in Artificial Intelligence (2022) Vol. 5
Open Access | Times Cited: 11
Microbiome in drug resistance to colon cancer
Kavita Pandey, Shahid Umar
Current Opinion in Physiology (2021) Vol. 23, pp. 100472-100472
Open Access | Times Cited: 13
Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
Daxiang Zhou, Xiong Shu, Juan Xiong, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
The baseline oral microbiota predicts the response of locally advanced oral squamous cell carcinoma patients to induction chemotherapy: A prospective longitudinal study
Mengyu Rui, Xinyi Zhang, Jinyun Huang, et al.
Radiotherapy and Oncology (2021) Vol. 164, pp. 83-91
Closed Access | Times Cited: 10
Gut resistome profiling reveals high diversity and fluctuations in pancreatic cancer cohorts
Xudong Liu, Kexin Li, Yun Yang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top